NeolPharma SEMAGLUTIDE 10MG

  • Proven 15–20%+ body weight loss in research protocols
  • Effortless appetite control + metabolic optimization
  • Muscle-sparing fat loss with cardiovascular benefits
  • Long-acting weekly injection for sustainable recomposition
  • The #1 research peptide for obesity, diabetes, and longevity studies

The revolutionary GLP-1 peptide for dramatic fat loss, appetite suppression, and improved metabolic health – the same compound behind blockbuster weight-loss results, now in research-grade purity.

Category: Tags: ,

NeolPharma SEMAGLUTIDE 10 is pharmaceutical-grade Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, supplied as 10 mg of lyophilized powder per vial for reconstitution. This orange-top vial delivers the exact same high-purity peptide used in clinical weight-management and diabetes research, offering powerful appetite control, fat loss, and insulin sensitivity enhancement.

Benefits

  • Significant and sustained fat loss (10–20%+ body weight reduction in 12–20 weeks)
  • Powerful appetite suppression and reduced cravings – makes dieting effortless
  • Improved insulin sensitivity and blood glucose control
  • Enhanced cardiovascular markers (lower blood pressure, improved lipids)
  • Increased satiety and better portion control without stimulants
  • Preservation of lean muscle mass during caloric deficit
  • Potential anti-aging and metabolic health benefits from GLP-1 activation
  • The gold-standard peptide for long-term body recomposition and obesity research

Usage Instructions

  • Dosage: Beginners: Start at 0.25 mg/week – Standard: 0.5–1.0 mg/week – Advanced/Weight loss: 1.0–2.4 mg/week (titrated slowly)
  • Administration: Subcutaneous injection (abdomen, thigh) once weekly
  • Cycle length: 12–24+ weeks (long-term use common; titrate up over 4–8 weeks to minimize nausea)
  • Reconstitution: Add 2–3 ml bacteriostatic water (e.g., 2 ml = 5 mg/ml) → gently swirl → refrigerate
  • Best timing: Same day each week; with or without food
  • Storage: 2–8°C after reconstitution (stable 4–6 weeks)

Cautions

  • Common side effects: nausea, vomiting, diarrhea (minimize by slow titration)
  • May cause hypoglycemia if combined with insulin or sulfonylureas
  • Contraindicated in medullary thyroid carcinoma history or multiple endocrine neoplasia syndrome
  • Keep refrigerated; discard if solution clouds or seal is broken

Reviews

There are no reviews yet.

Be the first to review “NeolPharma SEMAGLUTIDE 10MG”

Your email address will not be published. Required fields are marked *

Scroll to Top